Advertising Disclaimer

Learn more at drivemedical.com…

American Association for Respiratory Care

Nav

Breakfast & Lunch Symposia

Held at the Mandalay Bay South Convention Center, symposia are free of charge and most are approved for CRCE credit. The schedule below shows the companies hosting the symposia. Please note that the companies provided all topics, speakers, and descriptions, and they (not the AARC) are fully responsible for information presented at these sessions.

Complimentary breakfast and/or lunch. Attendance is limited, first-come, first-served once registration opens.

Wednesday, Dec. 10

6:30 am: Registration & Breakfast
7:00 am– 8:00 am: Symposium
South Seas F Ballroom
Presented by Masimo

Description: Masimo

Meeting Recent Guidance from The Joint Commission and CMS on Alarm Safety, Opioid Safety, Blood Transfusions, Hospital Acquired Conditions, and 30 Day Readmissions
Jon Carlson BS, RRT-NPS, Buffalo, NY
Garry Kauffman MPA, FACHE, RRT, FAARC, Winston Salem, NC

Program Overview

The Joint Commission National Patient Safety Goal on Alarm Safety became effective July 1, 2014 and Phase 2 will be implemented in 2016. Additionally in 2014 the Centers for Medicare & Medicaid Services (CMS) released updated guidance on the safety of IV opioids and blood transfusions as well as larger penalties for hospital acquired conditions and 30 day readmissions. Clinically and cost-effective non-invasive monitoring technology exists that can support hospital efforts to achieve these goals.

The first presentation will review The Joint Commission National Patient Safety Goal on Alarm Safety. This section will discuss the components of the NPSG, potential means of meeting this NPSG, and the role of technology in alarm safety.

The second presentation will review CMS updated guidance on IV opioid safety and blood transfusions, hospital acquired conditions, and 30-day readmissions. Attendees will learn about existing and new technology that can improve their ability to meet these goals and care for their patients in both critical and non-critical care units.

This course has been submitted to the American Association for Respiratory Care for CRCE approval. Course number is pending.

Register

Wednesday, Dec. 10

6:00 am: Registration & Continental Breakfast
6:30 am – 8:10 am: Symposium
South Seas E Ballroom
Presented by the American Association for Respiratory Care

Respiratory Compromise and the Role of the Respiratory Therapist
Lori Conklin MD, Charlottesville, VA
Paul Nuccio MS, RRT, FAARC, Boston, MA
Damien Beilman RRT, Wichita, KS

Program Overview
6:30am – 7:00am
Lori Conklin MD, Charlottesville, VA
The Clinical Impact of Respiratory Compromise: An Evaluation of the Events Leading Up To, During & After the Diagnosis

This presentation will discuss the science behind respiratory compromise and provide the attendee with a better understanding of patients who are at greatest risk for RC, the treatment of and the cascading effect that RC has on the patient. Clinical outcomes will be discussed for patients who suffer from RC.

7:05am – 7:35am
Paul Nuccio MS, RRT, FAARC, Boston, MA
The Financial Impact Respiratory Compromise Has on the Healthcare System

This presentation will discuss the business case behind RC and the impact it has on the American healthcare system. Discussion will take place around the financial impact RC has on reimbursement, potential impact (readmissions), and actual impact effecting department equipment and human resources. The presenter will discuss opportunity costs (savings) to the healthcare system by discussing treatment modalities and continuous monitoring costs as it relates to cost avoidance.

7:40am – 8:10am
Damien Beilman RRT, Wichita, KS
Real Life Applications for Preventing Respiratory Compromise

This presentation will highlight efforts taken by a Respiratory Care Department to prevent respiratory compromise. Outcomes and best practices will be discussed.

This course is supported through an unrestricted educational grant from Covidien

Description: Covidien

The American Association for Respiratory Care has approved this course for 1.50 CRCE. Course Number: 143335000

Register

Wednesday, Dec. 10

12:30 pm – 1:30 pm
South Seas E Ballroom
Presented by Boehringer Ingelheim

Boehringer Ingelheim

The Diagnosis and Treatment of IPF
Marilyn K. Glassberg MD, Miami, FL

Program Overview

The diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) will be explored in this presentation. This session will review important concepts related to the recognition of this disease as well as the use of pulmonary function testing to diagnose and monitor patients. Additionally, the role of the respiratory therapist in helping patients with IPF will be discussed.

Admission to this course is complimentary. No registration is required. Seating is on a first come, first served basis and is limited to the first 250 attendees.

This course is NOT eligible for CRCE credit.

Thursday, Dec. 11

6:00 am – 8:00 am
South Seas E Ballroom
Presented by Maquet

Maquet

Integrating NAVA Into Your Intensive Care Practices
Howard M. Stein MD, Toledo, OH
Kimberly S. Firestone BS, RRT, Akron, OH
Dan L. Stewart MD, FAAP, Louisville, KY

Program Overview

At the 2014 Maquet Breakfast Symposium, join us for a review of the latest data and clinical experience regarding NAVA® (Neurally Adjusted Ventilatory Assist) technology. The symposium will help you gain advanced insight into new technology adoption best practices used by clinicians to support integration of NAVA into their intensive care units.

The American Association for Respiratory Care has approved this course for 2.0 CRCE. Course Number: 143074000

Register

Thursday, Dec. 11

7:15 am – 8:15 am
South Seas F Ballroom
Presented by Philips

Respironics

Therapy driven COPD management program successful in reducing hospital admissions
Amy Day RRT, Dothan, AL

Program Overview

Treatment of patients with chronic obstructive pulmonary disease (COPD) places a financial burden on the US healthcare system with most of the cost resulting from hospitalizations for acute exacerbation of the disease. The use of noninvasive ventilation (NIV) in patients with severe COPD as a means of preventing subsequent hospitalization is currently controversial.  Retrospectively analyzed, the Barnes Healthcare Services Ventilation Management program has proven that late stage COPD patients are benefitting from the use of NIV with Trilogy100, therefore reducing overall healthcare costs.

This course is NOT eligible for CRCE credit.


Register

Thursday, Dec. 11

12:30 pm – 1:30 pm
South Seas F Ballroom
Presented by IKARIA

Nitric Oxide Delivery in Neonatal Noninvasive Respiratory Support Devices
Rob DiBlasi RRT-NPS, Snoqualmie, WA

Program Overview

Review of a recent study designed to evaluate the delivered dose of inhaled nitric oxide with neonatal noninvasive respiratory support devices via an infant lung model.

Topics will include

  • A description of the role of noninvasive respiratory support devices with neonates.
  • A discussion about the INOmax DSIR validations.
  • A review of a bench study that evaluated iNO stability, NO2 production, and pressures during INOmax delivery

This course is NOT eligible for CRCE credit.


Register

Friday, Dec. 12

6:00 am: Registration & Breakfast
6:30 am – 8:00 am: Symposium
South Seas F Ballroom
Presented by Integrity Continuing Education, Inc.

Hospital Discharge of Patients with COPD: Reducing Risk for Future Exacerbations and Readmission CRCE Symposium
Patrick J. Dunne MEd, RRT, FAARC, Fullerton, CA
Stanley B. Fiel MD, FACP, FCCP, Morristown, NJ

Program Overview

Chronic obstructive pulmonary disease (COPD) is a condition that poses a significant health and economic burden due to its high prevalence, chronicity, comorbidities, complexities, and progressive nature. When patients with the disease present to the hospital for an acute exacerbation, provision of appropriate pharmacologic and non-pharmacologic treatment requires that objective measures be employed to confirm diagnosis, and assess disease severity and the risk for future exacerbations. Through the collaborative efforts of a multidisciplinary team of clinicians including the participation of a respiratory therapist, these goals can be attained and patients can be provided with education and training to ensure that they are adequately equipped to achieve optimal control of their disease.

This course is supported through an unrestricted educational grant from Sunovion Pharmaceuticals, Inc.

This course has been submitted to the American Association for Respiratory Care for CRCE approval. Course number is pending.

Register